Plasma homocysteine and the severity of heart failure in patients with previous myocardial infarction

Cardiology Journal

Volumn 18, Issue 1, 2011, Pages 55-62

  Agoston Coldea, Lucia ^a   Mocan, Teodora ^a   Gatfosse, Marc ^b   Lupu, Silvia ^a   Dumitrascu, Dan L ^a  

^a IULIU HATIEGANU UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

^b 'Rene Arbeltier' Hospital   (France)

Author keywords

Heart failure; Homocysteine; Left ventricular dysfunction; Myocardial infarction

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; CHOLESTEROL; CREATININE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HOMOCYSTEINE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AMINO ACID BLOOD LEVEL; ARTICLE; BLOOD SAMPLING; BODY MASS; CONTROLLED STUDY; DIABETES MELLITUS; DIASTOLE; DISEASE COURSE; DISEASE SEVERITY; FAMILY HISTORY; FEMALE; HEART FAILURE; HEART INFARCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HEART LEFT VENTRICLE FAILURE; HEART LEFT VENTRICLE RELAXATION; HEART VENTRICLE SIZE; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; OBESITY; RISK FACTOR; SMOKING; SYSTOLIC BLOOD PRESSURE; WAIST CIRCUMFERENCE;

AGED; BIOLOGICAL MARKERS; CHI-SQUARE DISTRIBUTION; CHRONIC DISEASE; CROSS-SECTIONAL STUDIES; ECHOCARDIOGRAPHY, DOPPLER; FEMALE; FLUORESCENCE POLARIZATION IMMUNOASSAY; HEART FAILURE; HOMOCYSTEINE; HUMANS; HYPERHOMOCYSTEINEMIA; LOGISTIC MODELS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; ODDS RATIO; PREDICTIVE VALUE OF TESTS; RISK ASSESSMENT; RISK FACTORS; SEVERITY OF ILLNESS INDEX; STROKE VOLUME; UP-REGULATION; VENTRICULAR FUNCTION, LEFT;

EID: 79951491488     PISSN: 18975593     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Fox KF, Cowie MR, Wood DA et al. Coronary artery disease as the cause of incident heart failure in the population. Eur Heart J, 2001; 22: 228-236.
2. Ingelsson E, Ärnlöv J, Sundström J, Zethelius B, Vessby B, Lind L. Novel metabolic risk factors for heart failure. J Am Coll Cardiol, 2005; 46: 2054-2060.
3. Schocken DD, Benjamin EJ, Fonarow GC et al. Prevention of heart failure: A Scientific Statement From the American Heart Association Councils on Epidemiology and Prevention, Clinical Cardiology, Cardiovascular Nursing, and High Blood Pressure Research; Quality of Care and Outcomes Research Interdisciplinary Working Group; and Functional Genomics and Translational Biology Interdisciplinary Working Group. Circulation, 2008; 117: 2544-2565.
4. Vasan RS, Beiser A, D'Agostino RB et al. Plasma homocysteine and risk for congestive heart failure in adults without prior myocardial infarction. JAMA, 2003; 289: 1251-1257.
5. Sundstrom J, Sullivan L, Selhub J et al. Relations of plasma homocysteine to left ventricular structure and function: The Framingham Heart Study. Eur Heart J, 2004; 25: 523-530.
6. Vizzardi E, Bonadei I, Zanini G et al. Homocysteine and heart failure: An overview. Recent Pat Cardiovasc Drug Discov, 2009; 1: 15-21.
7. Tyagi SC, Rodriguez W, Patel AM et al. Hyperhomocysteinemic diabetic cardiomyopathy: Oxidative stress, remodeling, and endothelial- myocyte uncoupling. J Cardiovasc Pharmacol Ther, 2005; 10: 1-10.
8. Herrmann M, Taban-Shomal O, Ulrich Hubner U, Bohm M, Herrmann W. A review of homocysteine and heart failure. Eur J Heart Fail, 2006; 8: 571-576.
9. Kang SS, Wong PW, Malinow MR. Hyperhomocyst(e)inemia as a risk factor for occlusive vascular disease. Annu Rev Nutr, 1992; 12: 279-298.
10. Humphrey LL, Fu R, Rogers K, Freeman M, Helfand M. Homocysteine level and coronary heart disease incidence: A systematic review and meta-analysis. Mayo Clin Proc, 2008; 83: 1203-1212.
11. Nurk E, Tell GS, Vollset SE, Nygard O, Refsum H, Ueland PM. Plasma total homocysteine and hospitalizations for cardiovascular disease: The Hordaland Homocysteine Study. Arch Intern Med, 2002; 162: 1374-1381.
12. Weir RA, McMurray JJ. Epidemiology of heart failure and left ventricular dysfunction after acute myocardial infarction. Curr Heart Fail Rep, 2006; 3: 175-180.
13. Lang RM, Bierig M, Devereux RB. Recommendations for chamber quantification: A report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr, 2005; 18: 1440-1463.
14. Nagueh SF, Middleton KJ, Kopelen HA, Zoghbi WA, Quinones MA. Doppler tissue imaging: A noninvasive technique for evaluation of left ventricular relaxation and estimation of filling pressures. J Am Coll Cardiol, 1997; 30: 1527-1533.
15. Shipchandler MT, Moore EG. Rapid, fully automated measurement of plasma homocyst(e)ine with the Abbott Imx Analyzer. Clin Chem, 1995; 41: 991-994.
16. BNP test for rapid quantification of B-type natriuretic peptide [package insert]. Biosite Diagnostics, San Diego, California 2000.
17. Grundy SM, Becker D, Clark LT et al. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Circulation, 2002; 106: 3143-3421.
18. Nasir K, Tsai M, Rosen BD et al. Elevated homocysteine is associated with reduced regional left ventricular function. The Multi-Ethnic Study of Atherosclerosis. Circulation, 2007; 115: 180-187.
19. Miller A, Mujumdar V, Palmer L, Bower JD, Tyagi SC. Reversal of endocardial endothelial dysfunction by folic acid in homocysteinemic hypertensive rats. Am J Hypertens, 2002; 15: 157-163.
20. Cho SE, Sook HK, Shin GJ, Chung WS. The methylenetetrahydrofolate reductase C677T gene mutation is associated with hyperhomocysteinemia, cardiovascular disease and plasma B-type natriuretic peptide concentrations in Korea. Clin Chem Lab Med, 2006; 44: 1070-1075.
21. Hammerer-Lercher A, Ludwig W, Falkensammer G et al. Natriuretic peptides as markers of mild forms of left ventricular dysfunction: Effects of assays on diagnostic performance of markers. Clin Chem, 2004; 50: 1174-1183.
22. Hobbs FD, Davis RC, Roalfe AK, Hare R, Davies MK. Reliability of N-terminal proBNP assay in diagnosis of left ventricular systolic dysfunction within representative and high risk populations. Heart, 2004; 90: 866-870.
23. Rosenkranz AC, Woods RL, Dusting GJ, Ritchie RH. Antihypertrophic actions of the natriuretic peptides in adult rat cardiomyocytes: importance of cyclic GMP. Cardiovasc Res, 2003; 57: 515-522.
24. Herrmann M, Kindermann I, Muller S et al. Relationship of plasma homocysteine with the severity of chronic heart failure. Clin Chem, 2005; 51: 1512-1515.
25. Cooke GE, Eaton GM, Whitby G et al. Plasma atherogenic markers in congestive heart failure and posttransplant (heart) patients. J Am Coll Cardiol, 2000; 36: 509-516.
26. Stampfer MJ, Malinow MR, Willett WC et al. A prospective study of plasma homocyst(e)ine and risk of myocardial infarction in US physicians. JAMA, 1992; 268: 877-881.
27. Chasan-Taber L, Selhub J, Rosenberg IH et al. A prospective study of folate and vitamin B6 and risk of myocardial infarction in US physicians. J Am Coll Nutr, 1996; 15: 136-143.
28. Bostom AG, Silbershatz H, Rosenberg IH et al. Nonfasting plasma total homocysteine levels and all-cause and cardiovascular disease mortality in elderly Framingham men and women. Arch Intern Med, 1999; 159: 1077-1080.
29. Folsom AR, Nieto FJ, McGovern PG et al. Prospective study of coronary heart disease incidence in relation to fasting total homocysteine, related genetic polymorphisms, and B vitamins: The Atherosclerosis Risk in Communities (ARIC) study. Circulation, 1998; 98: 204-210.
30. Fallon UB, Ben-Shlomo Y, Elwood P, Ubbink JB, Smith GD. Homocysteine and coronary heart disease in the Caperhilly cohort: A 10 year follow-up. Heart, 2001; 85: 153-158.
31. Homocysteine Studies Collaboration. Homocysteine and risk of ischemic heart disease and stroke: A meta-analysis. JAMA, 2002; 288: 2015-2022.
32. Mann JFE, Sheridan P, McQueen MJ et al. Homocysteine lowering with folic acid and B vitamins in people with chronic kidney disease: Results of the renal Hope-2 study. Nephrol Dial Transplant, 2008; 23: 645-653.